Literature DB >> 15045518

Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone.

Stefan Uckert1, Petter Hedlund, Eginhard Waldkirch, Michael Sohn, Udo Jonas, Karl-Erik Andersson, Christian G Stief.   

Abstract

Nitric oxide (NO)/cyclic GMP (cGMP)-mediated mechanisms have a pivotal function in reducing the tone of the penile smooth musculature during normal erectile responses. The cyclic AMP (cAMP) signaling pathway is also involved in the adjustment of smooth muscle contractility, and suggestions for interactions between cGMP- and cAMP-mediated mechanisms have been presented. Using activators of the cGMP- or the cAMP-pathway, as well as inhibitors of protein kinase A (PKA; cAMP-dependent kinase) and protein kinase G (PKG; cGMP-dependent kinase), the present study was undertaken to further delineate the functional relation between these pathways in the penis. In addition, the distribution of PKA and some cAMP-binding phosphodiesterases (cAMP-PDEs) were investigated in human erectile tissue. Functional experiments were performed on isolated human corpus cavernosum (HCC). The effects of an inhibitor of the PKA, Rp-8CPT-cAMPS (10 microM), or the PKG, Rp-8-pCPT-cGMPS (10 microM), on relaxation induced by the cumulative administration of sodium nitroprusside (SNP), forskolin, sildenafil or tadalafil (IC351) were studied in preparations of HCC precontracted with 1 microM norepinephrine (NE). Using immunohistochemical procedures, the presence of immunoreactivity for cAMP-PDEs PDE3, PDE4, and PDE4A, as well as for PKA was investigated in specimens of HCC from which preparations were also used in the functional experiments. Forskolin, SNP, sildenafil, and IC 351 dose-dependently reversed NE-induced tension of isolated HCC preparations. The relaxing effects of SNP were significantly attenuated by Rp-8-pCPT-cGMPS, but not by Rp-8CPT-cAMPS. In contrast, relaxation induced by forskolin, sildenafil and tadalafil were significantly reversed by both Rp-8-pCPT-cGMPS and Rp-8CPT-cAMPS. Abundant immunoreactivity for PDE3 and PKA was observed in the corpus cavernosum smooth muscle cells. Immunoreactivity for PDE4 was also detected in the smooth musculature and in the cytoplasm of endothelial cells lining the cavernous sinusoids, as well as in nerve fibres interspersing the trabecular stroma. The present results support the hypothesis of interactions between cGMP- and cAMP-mediated signals in the HCC, and suggest that the effects of inhibitors of PDE5 on isolated erectile tissue may also partly or indirectly include actions of the cAMP second messenger system. The exact mechanism by which such an interaction occurs is not clear, but it may involve altered activity of the cGMP-inhibited PDE3 brought about by a change in the intracellular levels of cGMP by the inhibition of PDE5. This will in turn lead to increasing levels of cAMP, facilitating the interaction of cAMP with the PKA. The immunoreactivity specific for PDE3, PDE4, PDE4A and PKA registered in HCC section is also in support of an important role for the cAMP/PKA-system for penile smooth muscle function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15045518     DOI: 10.1007/s00345-003-0394-4

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  24 in total

1.  Allosteric sites of phosphodiesterase-5 (PDE5). A potential role in negative feedback regulation of cGMP signaling in corpus cavernosum.

Authors:  V K Gopal; S H Francis; J D Corbin
Journal:  Eur J Biochem       Date:  2001-06

2.  Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue.

Authors:  C G Stief; S Uckert; A J Becker; W Harringer; M C Truss; W G Forssmann; U Jonas
Journal:  Urology       Date:  2000-01       Impact factor: 2.649

Review 3.  Roflumilast Altana Pharma.

Authors:  Peter Reid
Journal:  Curr Opin Investig Drugs       Date:  2002-08

4.  Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

Authors:  I Goldstein; T F Lue; H Padma-Nathan; R C Rosen; W D Steers; P A Wicker
Journal:  N Engl J Med       Date:  1998-05-14       Impact factor: 91.245

5.  Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice.

Authors:  P Hedlund; A Aszodi; A Pfeifer; P Alm; F Hofmann; M Ahmad; R Fassler; K E Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

6.  Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.

Authors:  S A Ballard; C J Gingell; K Tang; L A Turner; M E Price; A M Naylor
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

7.  Discovery of L-791,943: a potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor.

Authors:  Daniel Guay; Pierre Hamel; Marc Blouin; Christine Brideau; Chi Chung Chan; Nathalie Chauret; Yves Ducharme; Zheng Huang; Mario Girard; Tom R Jones; France Laliberté; Paul Masson; Malia McAuliffe; Hanna Piechuta; José Silva; Robert N Young; Yves Girard
Journal:  Bioorg Med Chem Lett       Date:  2002-06-03       Impact factor: 2.823

8.  Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle.

Authors:  V Sauzeau; H Le Jeune; C Cario-Toumaniantz; A Smolenski; S M Lohmann; J Bertoglio; P Chardin; P Pacaud; G Loirand
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

9.  Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.

Authors:  P J Silver; R L Dundore; D C Bode; L de Garavilla; R A Buchholz; G van Aller; L T Hamel; E Bacon; B Singh; G Y Lesher
Journal:  J Pharmacol Exp Ther       Date:  1994-12       Impact factor: 4.030

10.  Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction.

Authors:  M C Truss; A J Becker; M H Djamilian; C G Stief; U Jonas
Journal:  Urology       Date:  1994-10       Impact factor: 2.649

View more
  13 in total

1.  Protein kinase enzymes in the human vagina-relation to key mediators of the cyclic AMP and cyclic GMP pathways.

Authors:  S Ückert; J Sonnenberg; J E Sonnenberg; W Kauffels; K Albrecht; M A Kuczyk; P Hedlund
Journal:  Int J Impot Res       Date:  2017-04-13       Impact factor: 2.896

2.  In vitro and in vivo studies on the importance of the soluble guanylyl cyclase α1 subunit in penile erection.

Authors:  Kelly Decaluwé; Sofie Nimmegeers; Robrecht Thoonen; Emanuel Buys; Peter Brouckaert; Johan Van de Voorde
Journal:  World J Urol       Date:  2010-01-23       Impact factor: 4.226

3.  Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries--immunohistochemical distribution and functional significance.

Authors:  Eginhard Waldkirch; Stefan Uckert; Hüseyin Yildirim; Michael Sohn; Udo Jonas; Christian G Stief; Karl-Erik Andersson; Petter Hedlund
Journal:  World J Urol       Date:  2005-11-15       Impact factor: 4.226

4.  Relaxant effect and possible mechanism of 17-nor-subincanadine E in rabbit corpora cavernosa.

Authors:  Otacilio D Benvindo; Nilberto Rf Nascimento; Claudia F Santos; Manasses C Fonteles; Edilberto R Silveira; Daniel E Uchoa; Adriana R Campos; Karina Ma Cunha; Flavia A Santos; Vietla S Rao
Journal:  Asian J Androl       Date:  2011-07-18       Impact factor: 3.285

Review 5.  Tadalafil: in the treatment of signs and symptoms of benign prostatic hyperplasia with or without erectile dysfunction.

Authors:  Monique P Curran
Journal:  Drugs Aging       Date:  2012-09       Impact factor: 3.923

6.  Role of cGMP and cAMP in the hemodynamic response to intrathecal sildenafil administration.

Authors:  Gabriela Bombarda; João Paulo J Sabino; Carlos Alberto A da Silva; Rubens Fazan; Maria Cristina O Salgado; Helio C Salgado
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Discovery of a highly specific 18F-labeled PET ligand for phosphodiesterase 10A enabled by novel spirocyclic iodonium ylide radiofluorination.

Authors:  Zhiwei Xiao; Huiyi Wei; Yi Xu; Ahmed Haider; Junjie Wei; Shiyu Yuan; Jian Rong; Chunyu Zhao; Guocong Li; Weibin Zhang; Huangcan Chen; Yuefeng Li; Lingling Zhang; Jiyun Sun; Shaojuan Zhang; Hai-Bin Luo; Sen Yan; Qijun Cai; Lu Hou; Chao Che; Steven H Liang; Lu Wang
Journal:  Acta Pharm Sin B       Date:  2021-11-17       Impact factor: 14.903

8.  Hypercontractility and impaired sildenafil relaxations in the BKCa channel deletion model of erectile dysfunction.

Authors:  Matthias E Werner; Andrea L Meredith; Richard W Aldrich; Mark T Nelson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-14       Impact factor: 3.619

9.  Protein kinase A facilitates relaxation of mouse ileum via phosphorylation of neuronal nitric oxide synthase.

Authors:  Damian D Guerra; Rachael Bok; Ramón A Lorca; K Joseph Hurt
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

10.  Effect of hypothyroidism on the purinergic responses of corpus cavernosal smooth muscle in rabbits.

Authors:  M K Yildirim; I Bagcivan; B Sarac; H Kilicarslan; S Yildirim; T Kaya
Journal:  Int Urol Nephrol       Date:  2008-03-08       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.